Wednesday, July 8, 2026

pharma · Opioid Use Disorder · Opioid Dependence

Indivior Pty

Indivior Pty trial registry — 47 ClinicalTrials.gov studies with program phase, status, and indication context.

., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
Status
Public
HQ
., Richmond, VA, US
Employees
967
Programs
39
Drugs
19
Patents
34
Intelligence · Clinical Trials

Indivior Pty clinical trials

Registry index of 47 ClinicalTrials.gov studies linked to Indivior Pty programs — each row shows trial ID, program name, phase, status, and indication.

Indivior Pty trial registry — 47 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Indivior Pty.

  1. INDV-6000-406 — Approved

    Clinical update
  2. P04843 — Approved

    Clinical update
  3. SUBOXONE sublingual film — Phase 3

    Clinical update
  4. Suboxone Sublingual Film — Approved

    Clinical update
  5. SUBOXONE — Phase 3

    Clinical update
  6. morphine sulfate — Unknown

    Clinical update
  7. Buprenorphine (Subutex) — Approved

    Clinical update
  8. Buprenorphine soluble film — Phase 2

    Clinical update

Trial registry

47 studies